Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization
IntroductionMultiple myeloma (MM) remains incurable, despite the advent of chimeric antigen receptor (CAR)-T cell therapy. This unfulfilled potential can be attributed to two untackled issues: the lack of suitable CAR targets and formats. In relation to the former, the target should be highly expres...
Main Authors: | Heleen Hanssens, Fien Meeus, Yannick De Vlaeminck, Quentin Lecocq, Janik Puttemans, Pieterjan Debie, Timo W. M. De Groof, Cleo Goyvaerts, Kim De Veirman, Karine Breckpot, Nick Devoogdt |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1389018/full |
Similar Items
-
Preclinical Targeted α- and β<sup>−</sup>-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies
by: Janik Puttemans, et al.
Published: (2020-04-01) -
Decorating sdAbs with Chelators: Effect of Conjugation on Biodistribution and Functionality
by: Henri Baudhuin, et al.
Published: (2021-04-01) -
Application Progress of the Single Domain Antibody in Medicine
by: Huaping Tang, et al.
Published: (2023-02-01) -
A Novel Strategy for Screening Tumor-Specific Variable Domain of Heavy-Chain Antibodies
by: Abdur Rafique, et al.
Published: (2023-06-01) -
Therapeutic Phage Display-Derived Single-Domain Antibodies for Pandemic Preparedness
by: Janet M. Daly, et al.
Published: (2023-01-01)